Resources from the same session
Refining patient selection: Benefits and risks of treating unselected patient groups
Presenter: Seock-Ah Im
Session: Targeting DNA damage response (DDR): Next generation drugs and the importance of biomarkers
Resources:
Slides
Webcast
Other synthetic lethality targets
Presenter: Ruth Plummer
Session: Targeting DNA damage response (DDR): Next generation drugs and the importance of biomarkers
Resources:
Slides
Webcast